Materialise NV (MTLS)
NASDAQ:MTLS
Want to see MTLS full AI Analyst Report?
Earnings Data
Report Date
Jul 23, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.05Last Year’s EPS
0Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational and financial picture: revenue was stable despite FX headwinds, margins and adjusted profitability improved materially (adjusted EBITDA +>30%, adjusted EBIT up meaningfully), Medical reported solid growth with strategic product launches, software recurring revenue increased and software profitability improved, cash position strengthened, and sustainability and strategic portfolio actions were executed. Offsetting factors include FX-driven reported declines in some areas, an 8% YoY drop in Manufacturing revenue driven by softer prototyping and automotive demand, and the near‑term top‑line impact of divestments. On balance, the favorable profitability trends, cash generation, product and partnership momentum, and reaffirmed guidance outweigh the lowlights.Company Guidance
Stable Revenue with Margin Expansion
Q1 revenue of EUR 66.3 million was stable year‑on‑year (0% change) while gross profit rose to EUR 37.9 million and gross margin expanded to 57.2% (up from 55.3% year‑ago), demonstrating revenue resilience with improved unit economics.
Material Improvement in Profitability
Adjusted EBITDA increased to EUR 8.0 million (up >30% YoY) with an adjusted EBITDA margin of 12.1%. Adjusted EBIT improved to EUR 2.5 million (3.7% margin) versus EUR 0.6 million in the prior year quarter. Net profit was EUR 1.8 million (EUR 0.03 per share).
Medical Segment Growth and Product Launches
Materialise Medical revenue grew 7% to EUR 33.2 million (approximately +10% on a constant currency basis). Medical Devices grew ~11%. Key launches included custom-made PEEK cranio-maxillofacial implants (now available across most of Europe) and OrthoView 3D Hip, expanding CT-based planning capabilities and reinforcing the integrated medical ecosystem.
Software Business Progress and Recurring Revenue
Software revenue was EUR 9.6 million (down 1% reported, +5% constant currency). Recurring revenue represented 83% of software revenue (up from 81% a year ago). Adjusted EBITDA for Software rose 88% YoY to EUR 1.1 million, reflecting improved operating leverage during the cloud/subscription transition.
Strategic Partnerships and Product Distribution Wins
Expanded partnership with HP: Magics Print for HP will be included with the new MJF 1200 3D printer (broader access to lower/mid-range market). CO-AM Professional early access and presales progressed with 7 customers actively onboarding in May and full availability expected mid‑June 2026.
Manufacturing Sequential Improvement in Strategic Areas
Manufacturing revenue was EUR 23.5 million (down 8% YoY) but increased sequentially versus the prior three quarters, with growth in strategic areas such as aerospace, defense and semiconductor production. Adjusted EBITDA for Manufacturing turned positive to EUR 0.3 million.
Strong Cash Position and Positive Free Cash Flow
Cash reserve of EUR 133 million, gross debt reduced to EUR 60.1 million, and net cash of EUR 72.8 million (increase of ~EUR 2 million in the quarter). Operating cash flow ~EUR 7 million, capex EUR 1.5 million, and free cash flow after investing activities EUR 5.7 million.
Sustainability and Reporting Milestones
Published first annual report after Euronext listing and completed CSRD sustainability reporting. Exceeded GHG reduction targets with over 1,500 tons CO2 reduced across operations (rolling 2‑year cycle), >450 tons annual savings from switching PA12 to a carbon‑reduced version, and HQ solar park now supplies over 40% of site electricity.
Strategic Portfolio Repositioning
Announced transfers of RapidFit and the eyewear business to their management teams to operate independently (Materialise retains a minority stake in eyewear), enabling Materialise to concentrate capital and leadership on core focus segments while allowing those businesses greater agility.
Guidance Reaffirmation
Full-year 2026 guidance reaffirmed: revenue range EUR 273–283 million and adjusted EBIT guidance EUR 10–12 million despite divestments and ongoing macro uncertainty, signaling management confidence in execution and cost discipline.
MTLS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MTLS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $5.62 | $5.44 | -3.20% |
Feb 19, 2026 | $5.40 | $5.91 | +9.44% |
Oct 28, 2025 | $5.94 | $5.70 | -4.04% |
Jul 24, 2025 | $6.18 | $5.32 | -13.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Materialise NV (MTLS) report earnings?
Materialise NV (MTLS) is schdueled to report earning on Jul 23, 2026, Before Open (Confirmed).
What is Materialise NV (MTLS) earnings time?
Materialise NV (MTLS) earnings time is at Jul 23, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MTLS EPS forecast?
MTLS EPS forecast for the fiscal quarter 2026 (Q2) is 0.05.